Journal article
The impact of postchemotherapy nausea and vomiting on quality of life after moderately emetogenic chemotherapy
Abstract
The purpose of the study was to assess the impact of postchemotherapy nausea and vomiting (PCNV) after moderately emetogenic chemotherapy on health-related quality of life (HRQOL) in patients with cancer being treated in a routine clinical practice setting. The European Organization for Research and Treatment in Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30) was administered on day 2 and day 6 following moderately emetogenic …
Authors
Rusthoven JJ; Osoba D; Butts CA; Yelle L; Findlay H; Grenville A
Journal
Supportive Care in Cancer, Vol. 6, No. 4, pp. 389–395
Publisher
Springer Nature
Publication Date
June 1998
DOI
10.1007/s005200050182
ISSN
0941-4355